Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H4 clustered 7 (H4C7) encodes a replication-dependent histone protein that is a core component of the nucleosome, the primary packaging unit of eukaryotic chromatin. Two molecules each of the four core histones (H2A, H2B, H3, H4) form an octamer, around which DNA is wound. This packaging limits DNA accessibility to the cellular machinery involved in processes such as transcription, replication, repair, and chromosomal stability. H4C7 is intronless, encoded in a large histone gene cluster on chromosome 6, and its transcripts lack polyA tails, instead terminating with a palindromic sequence. Alterations in histone composition, including H4C7, may contribute to diseases such as cancer, with some evidence suggesting a role for H4G (H4C7) in regulating ribosomal DNA transcription in breast cancer[1][2][5][6]. Histones such as H4C7 are not typical therapeutic drug targets or disease biomarkers; rather, they are central chromatin components whose perturbation can have widespread effects on genome function.
not applicable (no direct-acting drugs or mechanism of pharmacological intervention reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H4 clustered 7 (H4C7).